IL17A and Obesity: These data suggest that a lack of IL-17RA, IL-17A or IL-17F uncouples steatosis from hepatocellular damage during MCDD-driven, obesity-independent, NAFLD and propose a novel role for IL-17F during disease pathogenesis.[3].